We sit down with you and build your perfect lead list. Book a call with founders.

Reticular Analysis

What is Reticular?

Reticular specializes in AI-driven solutions for drug discovery. Their unique approach utilizes curated knockout cohorts and extensive human datasets for target validation. This methodology accelerates drug development pipelines, enhancing confidence in research outcomes.

HQ Country
San Francisco, United States
Employees
1-10
Founded
2024
Industry
AI/ML, Biotech, Data Analytics

Product Features & Capabilities

  • AI-curated knockout cohorts for target validation
  • Rich human datasets for accelerated drug discovery
  • Proprietary algorithms for data analysis
  • Comprehensive research support for biopharma
  • Customizable demo sessions for potential clients.

How much Reticular raised

Pre-Seed - N/A

December 4, 2024
Lead Investor: Y Combinator

Accelerator/Incubator - N/A

January 1, 2024
Lead Investor: Not specified

Early Stage VC - N/A

June 1, 2025
Lead Investor: Not specified

Financial Overview

Pre-Seed
December 4, 2024
Investors: Y Combinator
Accelerator/Incubator
January 1, 2024
Investors: Not specified
Early Stage VC
June 1, 2025
Investors: Not specified
Want to research more data points on Reticular?
Start with Extruct